Iodine Drapes Used in TSA
Effect of Iodine Impregnated Drapes on the Rate of Positive Cultures in Primary Total Shoulder Arthroplasty - a Prospective, Randomized Study
1 other identifier
interventional
128
1 country
1
Brief Summary
This study will directly compare the positive culture rate in shoulder arthroplasty using iodine-impregnated versus non-iodine-impregnated drapes used during surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2026
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2025
CompletedStudy Start
First participant enrolled
January 5, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
July 23, 2026
July 1, 2026
4 years
December 29, 2025
July 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Culture positivity rate
One deep tissue swab will be taken after final implant placement and sent for culture to see if bacteria grows after surgery.
13 days
Study Arms (2)
Iodine Drapes
ACTIVE COMPARATORWhen the participant is in the operating room Surgical draping will be performed using cloth drapes impregnated with iodine
Non-iodine drapes
ACTIVE COMPARATORWhen the participant is in the operating room Surgical draping will be performed using standard cloth drapes
Interventions
After cleaning the shoulder area in preparation for surgery, the area will be covered and draped using iodine impregnated drapes prior to the start of the participants surgery.
One deep tissue swab will be taken after final shoulder implant placement and sent for culture to see if bacteria grows after surgery.
Participant will have total shoulder arthroplasty surgery
Eligibility Criteria
You may qualify if:
- Adults ≥ 18 years
- Written informed consent
- Elective primary total shoulder arthroplasty
- Male patients
You may not qualify if:
- Prior surgery on the operative shoulder
- Iodine allergy
- Participation in other clinical trials
- Active infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- tnicholsonlead
Study Sites (1)
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Surena Namdari, MD
Rothman Orthopaedic Institute
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Clinical Trials
Study Record Dates
First Submitted
December 29, 2025
First Posted
July 23, 2026
Study Start
January 5, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share